AFX.HA Carl Zeiss Meditec AG
- Market cap
- -
- P/E
- 25.4x
- P/B
- 1.45x
- ROE
- -
- Dividend yield
- 0.93%
- Fundamental score
- 2.0/5
Is AFX.HA undervalued?
Graham numberAFX.HA trades 27.8% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Carl Zeiss Meditec AG fundamental analysis
9 of 21 checks passedROE 0/2
Low return on equity (-0.9%), below 10%.
ROA 0/1
Return on assets (-0.6%) is below the industry median (3.1%).
Profit Consistency 2/2
Profitable for 7 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Last year's EPS growth (-21.0%) is not above the 5-year average (3.3% a year).
Earnings Growth vs Industry 0/1
Last year's EPS growth (-21.0%) is below the industry median (4.6%).
Revenue Growth 1/2
Revenue grew 5.4% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 2/2
Loss-making but free cash flow is positive.
PE vs Market 0/1
PE (25.4x) is above the market median (19.6x).
PE vs Industry 0/1
PE (25.4x) is above the industry median (18.2x).
PBV 1/1
Price to book (1.4x) is below the industry median (2.0x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 36.7, limit 22.5).
PEG 0/1
PEG on 5-year earnings growth is 7.59, above 1.
Dividend Yield 1/2
Dividend yield (1.5%) is above the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 1/1
Payout ratio is 37.2%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Carl Zeiss Meditec AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Carl Zeiss Meditec AG financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 1 quarter up to Dec 31, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
Carl Zeiss Meditec AG annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1.46B | 1.34B | 1.65B | 1.90B | 2.09B | 2.07B | 2.23B | 1.87B |
| Gross Profit | 832M | 746M | 967M | 1.13B | 1.21B | 1.09B | 1.18B | 908M |
| Operating Income | 265M | 178M | 374M | 397M | 348M | 194M | 223M | 4.00M |
| EBITDA | 286M | 267M | 410M | 483M | 502M | 403M | 347M | 8.00M |
| Net Income | 160M | 122M | 236M | 294M | 290M | 179M | 141M | -19.6M |
| EPS | 1.79 | 1.37 | 2.64 | 3.29 | 3.25 | 2.04 | 1.61 | - |
| Balance Sheet | ||||||||
| Total Assets | 2.02B | 2.01B | 2.40B | 2.82B | 3.03B | 3.39B | 3.40B | - |
| Total Liabilities | 605M | 563M | 719M | 793M | 860M | 1.34B | 1.28B | - |
| Shareholders' Equity | 1.40B | 1.43B | 1.66B | 2.02B | 2.16B | 2.04B | 2.12B | - |
| Cash & Short-term Investments | 22.6M | 5.20M | 7.44M | 7.73M | 10.6M | 20.3M | 27.3M | - |
| Cash Flow | ||||||||
| Operating Cash Flow | 220M | 179M | 363M | 188M | 251M | 247M | 210M | 66.8M |
| Capital Expenditure | 46.7M | 45.0M | 66.1M | 82.0M | 114M | 152M | 76.6M | 0.00 |
| Free Cash Flow | 173M | 134M | 297M | 106M | 137M | 95.1M | 133M | 66.8M |
| Ratios | ||||||||
| ROE | 11.4% | 8.5% | 14.2% | 14.6% | 13.4% | 8.8% | 6.7% | - |
| ROA | 7.9% | 6.1% | 9.9% | 10.4% | 9.6% | 5.3% | 4.1% | - |
| Net Profit Margin | 10.9% | 9.2% | 14.3% | 15.4% | 13.9% | 8.7% | 6.3% | -1.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Carl Zeiss Meditec AG dividends
- Dividend yield
- 0.93%
- Forward dividend
- -
- Payout ratio
- 37.2%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 52.5M | 0.60 | 37.2% |
| 2024 | EUR 98.2M | 1.12 | 54.9% |
| 2023 | EUR 98.4M | 1.10 | 33.9% |
| 2022 | EUR 80.5M | 0.90 | 27.4% |
| 2021 | EUR 44.7M | 0.50 | 18.9% |
| 2020 | EUR 58.1M | 0.65 | 47.5% |
| 2019 | EUR 49.2M | 0.55 | 30.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Carl Zeiss Meditec AG
Ownership data of Carl Zeiss Meditec AG is not available yet.
Carl Zeiss Meditec AG company profile
- Company name
- Carl Zeiss Meditec AG
- Ticker
- AFX.HA
- Exchange
- Hanover Exchange
- Sector
- Other
- Industry
- Metals & Mining
- Fiscal year end
- September
- Address
- Website
- -
About Carl Zeiss Meditec AG
There is no Profile data available for AFX.HA.